Danaher Corporation (DHR) fair value analysis

S&P 500 · Updated 2026-09-07

Danaher Corporation is a diversified conglomerate that operates through multiple segments providing products and services in life sciences, diagnostics, environmental and applied solutions, and dental products. The company operates globally across numerous countries and serves customers in research, clinical, environmental, and industrial markets worldwide.

Forward Fair Value verdict

Fairly valued

Based on TickrTrends' weekly Forward Fair Value model, DHR is trading at within about 10% of estimated fair value.

DHR currently ranks #62 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Fairly valued for 3 consecutive weekly runs.

Last price: $207.66
Sector: Healthcare
12-month range: $175.15–$230.40

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: B
Leverage: Low
Margin trend: Expanding
Revenue growth: Declining
RSI zone: Neutral
52-week position: The upper-middle quarter of its range
DCF cross-check: Overvalued

What our data shows for DHR

Our model validated 17 trailing price-to-earnings windows for DHR, built from quarterly earnings records.
Shares are trading in the middle of their 12-month price range of $175.15–$230.40.
The 14-day relative strength index sits at a neutral 53.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for DHR
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent DHR news

TickrTrends' derived news-sentiment signal for DHR is currently leaning positive, computed from recent coverage.

DHR Holdings leases 1.8 lakh sq ft in Bengaluru (economictimes.indiatimes.com, 2026-09-08)
TickrTrends take: DHR's expansion of its physical footprint in Bengaluru through a significant lease commitment reflects ongoing investment in operational capacity within a key global technology and services hub. For investors focused on valuation, this real estate commitment warrants monitoring of how the company deploys this expanded space to drive revenue growth and whether it translates into improved capital efficiency metrics. Given TickrTrends' assessment that DHR is fairly valued, observers should track whether this infrastructure investment yields returns that justify the associated fixed-cost obligations in coming quarters.
Danaher (DHR) Seen Deftly Navigating AI Integration (finance.yahoo.com, 2026-09-03)
TickrTrends take: Danaher's ability to integrate artificial intelligence across its operations positions it within a competitive landscape where Healthcare sector companies are increasingly adopting automation technologies. Given TickrTrends' current assessment that DHR is fairly valued, investors focused on valuation metrics should monitor whether successful AI implementation translates into measurable improvements in operational efficiency and margin expansion. The effectiveness of DHR's AI integration efforts may become a key factor in determining whether the current valuation multiple remains appropriate relative to peer companies navigating similar technology transitions.
Is Danaher Stock Underperforming the Nasdaq? (finance.yahoo.com, 2026-08-31)
TickrTrends take: Danaher operates in the Healthcare sector and is currently assessed as fairly valued according to TickrTrends metrics. The question of whether DHR is underperforming the Nasdaq relative to its valuation warrants attention, as a fairly valued stock trading below broader market momentum could indicate either a temporary disconnect or emerging headwinds specific to the company or its sector. Investors focused on valuation should monitor whether DHR's relative performance reflects genuine operational concerns or simply a rotation away from Healthcare names, which would help clarify whether the current valuation assessment remains appropriate.

What people are saying

Follow the DHR conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — TickrTrends' derived indicators for DHR show two changes this week. The momentum indicator, which was previously at A, is now showing none. The sector discount rank improved from number 68 to number 62, indicating a relatively stronger valuation position within the Healthcare sector. DHR maintains a Fairly valued verdict overall.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is DHR stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), DHR is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.

What is DHR's TickrTrends verdict?

DHR's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.

How does DHR compare to other Healthcare stocks?

DHR ranks #62 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is DHR overbought or oversold?

DHR's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

DHR vs A · DHR vs BAX · DHR vs ENSG · DHR vs INVA · DHR vs KNSA